These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2763831)

  • 41. [Comparison of nasal histamine and allergen provocations in patients with allergic rhinitis].
    Tahamiler R; Saritzali G; Canakçioğlu S
    Kulak Burun Bogaz Ihtis Derg; 2007; 17(1):30-6. PubMed ID: 17483609
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nasal conditioning in perennial allergic rhinitis after nasal allergen challenge.
    Rozsasi A; Leiacker R; Keck T
    Clin Exp Allergy; 2004 Jul; 34(7):1099-104. PubMed ID: 15248856
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nasal histamine reactivity; relationships to skin-test responses, allergen provocation and symptom severity in patients with long-continuing allergic rhinitis.
    Simola M; Malmberg H
    Acta Otolaryngol; 2000 Jan; 120(1):67-71. PubMed ID: 10779189
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Females have stronger neurogenic response than males after non-specific nasal challenge in patients with seasonal allergic rhinitis.
    Tomljenovic D; Baudoin T; Megla ZB; Geber G; Scadding G; Kalogjera L
    Med Hypotheses; 2018 Jul; 116():114-118. PubMed ID: 29857893
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of cold dry air nasal stimulation on airway mucosal blood flow in humans.
    Le Merre C; Isber J; Chediak AD; Wanner A
    Arch Physiol Biochem; 2003 Oct; 111(4):327-9. PubMed ID: 15764066
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of levocetirizine on nasal provocation testing with adenosine monophosphate compared with allergen challenge in allergic rhinitis.
    Vaidyanathan S; Nair A; Barnes ML; Meldrum K; Lipworth BJ
    Clin Exp Allergy; 2009 Mar; 39(3):409-16. PubMed ID: 19187327
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pollen derived low molecular compounds enhance the human allergen specific immune response in vivo.
    Gilles-Stein S; Beck I; Chaker A; Bas M; McIntyre M; Cifuentes L; Petersen A; Gutermuth J; Schmidt-Weber C; Behrendt H; Traidl-Hoffmann C
    Clin Exp Allergy; 2016 Oct; 46(10):1355-65. PubMed ID: 27061126
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immediate nasal response to allergen challenge cytologic changes in the nasal secretions and histologic changes in the nasal mucosa.
    Pelikan Z; Pelikan-Filipek M
    Adv Exp Med Biol; 1995; 371B():847-53. PubMed ID: 7502911
    [No Abstract]   [Full Text] [Related]  

  • 49. Basophil and eosinophil accumulation and mast cell degranulation in the nasal mucosa of patients with hay fever after local allergen provocation.
    KleinJan A; McEuen AR; Dijkstra MD; Buckley MG; Walls AF; Fokkens WJ
    J Allergy Clin Immunol; 2000 Oct; 106(4):677-86. PubMed ID: 11031338
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nasal nitric oxide: longitudinal reproducibility and the effects of a nasal allergen challenge in patients with allergic rhinitis.
    Boot JD; de Kam ML; Mascelli MA; Miller B; van Wijk RG; de Groot H; Cohen AF; Diamant Z
    Allergy; 2007 Apr; 62(4):378-84. PubMed ID: 17362248
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Late nasal response to allergen challenge cytologic changes in the nasal secretions and histologic changes in the nasal mucosa.
    Pelikan Z; Pelikan-Filipek M
    Adv Exp Med Biol; 1995; 371B():855-60. PubMed ID: 7502912
    [No Abstract]   [Full Text] [Related]  

  • 52. The time course of the bilateral release of cytokines and mediators after unilateral nasal allergen challenge.
    Wagenmann M; Schumacher L; Bachert C
    Allergy; 2005 Sep; 60(9):1132-8. PubMed ID: 16076297
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nasal nitric oxide and nasal allergy.
    Struben VM; Wieringa MH; Feenstra L; de Jongste JC
    Allergy; 2006 Jun; 61(6):665-70. PubMed ID: 16677234
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Desloratadine reduces allergen challenge-induced mucinous secretion and plasma exudation in allergic rhinitis.
    Greiff L; Persson CG; Andersson M
    Ann Allergy Asthma Immunol; 2002 Oct; 89(4):413-8. PubMed ID: 12392387
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fluticasone propionate aqueous nasal spray reduces inflammatory cells in unchallenged allergic nasal mucosa: effects of single allergen challenge.
    Holm A; Dijkstra M; Kleinjan A; Severijnen LA; Boks S; Mulder P; Fokkens W
    J Allergy Clin Immunol; 2001 Apr; 107(4):627-33. PubMed ID: 11295650
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Eotaxin, but not IL-8, is increased in upper and lower airways of allergic rhinitis subjects after nasal allergen challenge.
    Semik-Orzech A; Barczyk A; Wiaderkiewicz R; Pierzchała W
    Allergy Asthma Proc; 2011; 32(3):230-8. PubMed ID: 21703102
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Establishing a model of seasonal allergic rhinitis and demonstrating dose-response to a topical glucocorticosteroid.
    Ahlström-Emanuelsson C; Persson CG; Svensson C; Andersson M; Hosszu Z; Akerlund A; Greiff L
    Ann Allergy Asthma Immunol; 2002 Aug; 89(2):159-65. PubMed ID: 12197572
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Asthmatic response induced by nasal challenge with allergen.
    Pelikan Z
    Int Arch Allergy Immunol; 2009; 148(4):330-8. PubMed ID: 19001793
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Experimentally induced accumulation of Foxp3⁺ T cells in upper airway allergy.
    Skrindo I; Scheel C; Johansen FE; Jahnsen FL
    Clin Exp Allergy; 2011 Jul; 41(7):954-62. PubMed ID: 21418344
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnosing nasal hyperreactivity with positional rhinomanometry.
    Altissimi G; Gallucci L; Rossetti M; Simoncelli C
    Ann Otol Rhinol Laryngol; 1996 Nov; 105(11):901-4. PubMed ID: 8916867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.